Synlett 1997; 1997(4): 378-380
DOI: 10.1055/s-1997-802
letter
© Georg Thieme Verlag, Rüdigerstr. 14, 70469 Stuttgart, Germany. All rights reserved. This journal, including all individual contributions and illustrations published therein, is legally protected by copyright for the duration of the copyright period. Any use, exploitation or commercialization outside the narrow limits set by copyright legislation, without the publisher's consent, is illegal and liable to criminal prosecution. This applies in particular to photostat reproduction, copying, cyclostyling, mimeographing or duplication of any kind, translating, preparation of microfilms, and electronic data processing and storage.

2',3'-Cyclopropanated Nucleoside Dimers

Constantin G. Yannopoulos, Wen-Qiang Zhou, Peter Nower, Didier Peoc'h, Yogesh S. Sanghvi1 , George Just2
  • 1Isis Pharmaceuticals, 2292 Faraday Avenue, Carlsbad, CA 92008, USA
  • 2Department of Chemistry, McGill University, Montreal, Quebec, Canada H3A 2K6
Further Information

Publication History

Publication Date:
31 December 2000 (online)

Syntheses of three novel conformationally rigid dimers containing cyclopropyl -amide and -sulfonamide functionalities are described. Their incorporation into an oligonucleotide sequence resulted in considerable lowering of the Tm's in binding to their complementary RNA sequences.

    >